Baxter Competitors

Stocks . Brazil . 
Stock . Baxter International
B1AX34 Stock   97.30  4.28  4.60%   
Baxter International competes with Align Technology, Bread Financial, Mitsubishi UFJ, Palantir Technologies, and Dell Technologies; as well as few others. The company operates under Healthcare sector and is part of Medical Instruments & Supplies industry. Analyzing Baxter International competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Baxter International to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Baxter International Correlation with its peers.
For information on how to trade Baxter Stock refer to our How to Trade Baxter Stock guide.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Baxter International competition on your existing holdings.
  
Hype
Prediction
LowEstimatedHigh
0.000.001.94
Details
Intrinsic
Valuation
LowRealHigh
0.000.001.94
Details
Naive
Forecast
LowNextHigh
91.1193.0594.99
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
91.8495.8799.91
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Baxter International. Your research has to be compared to or analyzed against Baxter International's peers to derive any actionable benefits. When done correctly, Baxter International's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Baxter International.

Baxter International Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Baxter International and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Baxter and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Baxter International does not affect the price movement of the other competitor.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio
High positive correlations   
S1PO34
+ 0.94
P2LT34
D1EL34
+ 0.93
P2LT34
P2LT34
+ 0.89
M1UF34
D1EL34
+ 0.89
M1UF34
S1PO34
+ 0.88
D1EL34
S1PO34
+ 0.86
M1UF34
  
High negative correlations   
LUPA3
- 0.62
S1PO34
LUPA3
- 0.61
P2LT34
LUPA3
- 0.56
D1EL34
LUPA3
- 0.42
M1UF34
TECN3
- 0.3
A1LG34
D1EL34
- 0.27
A1LG34

Risk-Adjusted Indicators

There is a big difference between Baxter Stock performing well and Baxter International Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Baxter International's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
All Fundamental Data

Baxter International Competitive Analysis

The better you understand Baxter International competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Baxter International's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Baxter International's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
B1AX34 A1LG34 A1LL34 M1UF34 P2LT34 D1EL34 S1PO34 TECN3 LUPA3
 4.60 
 97.30 
Baxter
 0.00 
 327.36 
Align
 0.78 
 82.96 
Bread
 0.10 
 67.97 
Mitsubishi
 1.36 
 123.65 
Palantir
 2.62 
 830.56 
Dell
 0.67 
 689.51 
Spotify
 8.30 
 5.74 
Technos
 5.97 
 1.42 
Lupatech
Market Volatility
(90 Days Market Risk)
Out of control
Very steady
Very steady
Very steady
Very steady
Very steady
Very steady
Slightly risky
Very risky
Market Performance
(90 Days Performance)
Very Weak
Weak
Insignificant
Good
Strong
Good
Solid
Weak
Very Weak
Odds of Financial Distress
(Probability Of Bankruptcy)
Below Average
Low
Low
Below Average
Low
Low
Low
Low
Quite High
Current Valuation
(Equity Enterprise Value)
Under Valued
Over Valued
Over Valued
Over Valued
Over Valued
Under Valued
Over Valued
Over Valued
Fairly Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Not Rated
Strong Hold
Buy
Strong Buy
Hold
Strong Buy
Cautious Hold
Strong Hold
Strong Buy
Current Ratio
N/A
1.32
1.79
N/A
N/A
0.77
1.27
3.22
1.6
Net Asset
33.52 B
5.94 B
21.75 B
373.73 T
3.25 B
92.73 B
7.17 B
642.73 M
503.03 M
Profit Margin
-0.16
0.0968
0.0999
-0.22
-0.31
0.0174
-0.0367
0.1
-0.24
EBITDA
2.57 B
1.09 B
1.17 B
N/A
(469.96 M)
12.02 B
427 M
56.69 M
(21.86 M)
Operating Margin
0.12
0.18
0.13
-0.0607
-0.11
0.0588
-0.0554
0.17
-0.26
Current Valuation
217.71 B
76.27 B
N/A
N/A
69.57 B
282.72 B
70.65 B
200.74 M
246.95 M
Price To Book
4.81
4.19
0.8
0.58
6.56
N/A
6.15
0.45
1.0
Retained Earnings
N/A
N/A
N/A
N/A
N/A
N/A
N/A
191 M
N/A
Current Asset
N/A
N/A
N/A
N/A
N/A
N/A
N/A
465 M
N/A
Beta
0.55
1.62
2.0
0.87
2.89
0.99
1.77
1.57
1.16
Number Of Employees
60 K
10
6 K
129.7 K
3.71 K
133 K
8.36 K
15
454
Shares Outstanding
1.01 B
309.2 M
199.41 M
12.11 B
6.25 B
716.13 M
773.17 M
73.53 M
30.35 M
Cash Flow From Operations
2.22 B
1.17 B
1.54 B
909.36 B
333.85 M
10.31 B
361 M
42.46 M
(14.63 M)
Annual Yield
0.0283
N/A
0.0201
0.0313
N/A
0.0312
N/A
0.0353
N/A
Total Debt
17.15 B
96.73 M
7.43 B
14.57 T
N/A
21.13 B
1.2 B
123.67 M
90.59 M
Return On Equity
-0.32
0.1
0.1
-0.0425
-0.24
0.33
-0.19
0.11
-0.22
Z Score
3.6
N/A
0.6
N/A
N/A
5.2
62.8
0.6
0.6
Return On Asset
0.0375
0.0688
0.0095
-0.002
-0.0387
0.035
-0.0549
0.058
-0.037
Book Value Per Share
11.56
11.61
11.35
1375.64
1.15
-4.83
3.11
4.72
3.75
Current Liabilities
N/A
N/A
N/A
N/A
N/A
N/A
N/A
128 M
N/A
Total Asset
33.52 B
5.94 B
21.75 B
373.73 T
3.25 B
92.73 B
7.17 B
642.73 M
503.03 M
Last Dividend Paid
1.15
N/A
0.84
30.5
N/A
0.99
N/A
0.081
N/A
Debt To Equity
N/A
0.028
8.43
N/A
N/A
5.7
0.57
18.4
154.6
Target Price
N/A
N/A
N/A
N/A
N/A
N/A
N/A
5.0
3.8
Shares Owned By Institutions
N/A
N/A
N/A
N/A
N/A
0.007
N/A
22.47
4.05
Market Capitalization
107.74 B
129.2 B
11.16 B
466.62 B
82.52 B
161.91 B
124.49 B
173.54 M
153.28 M
Price To Earnings To Growth
1.7
10.92
0.2
6.58
1.41
1.18
N/A
N/A
N/A
Price To Earning
N/A
67.76
11.81
N/A
N/A
19.57
N/A
10.32
0.06
Price To Sales
9.63
21.83
4.32
0.1
42.39
1.55
6.56
0.46
1.03
Net Income
1.28 B
772.02 M
801 M
(83.32 B)
(520.38 M)
5.56 B
(34 M)
28.08 M
(41.34 M)
Earnings Per Share
5.18
5.47
10.44
1.28
-1.31
12.12
-0.77
0.43
8.22
Shares Owned By Insiders
N/A
N/A
N/A
N/A
N/A
N/A
N/A
40.67
20.37
Revenue
12.78 B
3.95 B
3.27 B
4.7 T
1.54 B
101.2 B
9.67 B
314.4 M
93.55 M
Working Capital
N/A
N/A
N/A
N/A
N/A
N/A
N/A
337 M
N/A
Cash And Equivalents
N/A
1.09 B
3 B
N/A
N/A
14.24 B
2.98 B
N/A
17.9 M
Cash Per Share
N/A
3.44
15.08
N/A
N/A
18.65
3.9
0.61
1.53
Gross Profit
6.03 B
2.63 B
1.6 B
2.95 T
1.2 B
21.89 B
2.93 B
165.18 M
25.24 M
Day Typical Price
97.3
327.36
82.96
67.92
122.3
831.77
690.72
5.6
1.42
Accumulation Distribution
N/A
N/A
N/A
0.0021
0.0471
0.0199
0.024
0.0783
0.0811
Market Facilitation Index
N/A
N/A
N/A
0.14
5.87
16.75
16.8
0.45
0.12
Daily Balance Of Power
9.2 T
0.0
9.2 T
(0.50)
0.2828
1.265075
0.2726
0.9778
0.6667
Period Momentum Indicator
4.28
N/A
0.64
(0.07)
1.66
21.19
4.58
0.44
0.08
Rate Of Daily Change
1.05
1.0
1.01
1.0
1.01
1.03
1.01
1.08
1.06
Day Median Price
97.3
327.36
82.96
67.9
121.63
832.38
691.32
5.53
1.42
Price Action Indicator
2.14
N/A
0.32
0.035
2.86
8.78
0.48
0.44
0.04
Relative Strength Index
92.12
4.6
41.84
13.99
54.75
15.5
57.47
58.26
89.57
Coefficient Of Variation
(45,180)
6018.37
1576.59
619.89
325.98
519.18
434.6
(3,419)
(1,746)
Mean Deviation
0.8439
0.4363
1.99
1.32
2.66
1.96
1.85
2.16
1.47
Jensen Alpha
(0.06)
0.0217
0.1204
0.2425
1.23
0.4264
0.6703
(0.08)
(0.20)
Total Risk Alpha
(0.31)
(0.18)
(0.34)
(0)
0.5698
0.0813
0.1831
(0.56)
(0.54)
Sortino Ratio
N/A
(0.04)
0.029
0.0996
0.4495
0.1546
0.1902
N/A
N/A
Downside Variance
N/A
9.77
10.48
2.47
5.57
5.73
6.4
N/A
N/A
Standard Deviation
1.88
1.23
3.54
1.78
3.88
2.6
2.66
2.95
2.47
Kurtosis
5.95
11.15
15.12
1.31
10.13
0.1639
5.88
1.01
6.99
Potential Upside
3.25
1.86
3.49
3.56
6.79
5.14
3.11
6.13
2.96
Treynor Ratio
(0.04)
(0.11)
0.2751
0.9628
(3.20)
0.9216
(1.06)
0.6286
(0.36)
Maximum Drawdown
12.71
10.68
24.55
8.0
25.1
11.42
18.04
13.33
17.3
Variance
3.54
1.51
12.55
3.17
15.08
6.76
7.07
8.72
6.12
Market Risk Adjusted Performance
(0.03)
(0.10)
0.2851
0.9728
(3.19)
0.9316
(1.05)
0.6386
(0.35)
Risk Adjusted Performance
0.0042
0.0165
0.0565
0.1294
0.2433
0.1548
0.1836
(0.02)
(0.04)
Skewness
(0.02)
(0.23)
2.04
0.7534
2.3
0.1654
0.8875
0.6399
1.46
Semi Deviation
N/A
0.8983
2.93
1.19
1.52
1.88
2.2
N/A
N/A
Information Ratio
(0.07)
(0.09)
0.0265
0.0879
0.2731
0.1423
0.1809
(0.07)
(0.11)
Value At Risk
(3.51)
(2.02)
(4.66)
(2.31)
(3.44)
(4.01)
(3.56)
(3.91)
(3.60)
Expected Short fall
N/A
(2.42)
(2.09)
(1.68)
(3.14)
(2.14)
(2.09)
N/A
N/A
Downside Deviation
N/A
3.13
3.24
1.57
2.36
2.39
2.53
N/A
N/A
Semi Variance
N/A
0.807
8.61
1.42
2.32
3.54
4.84
N/A
N/A

Baxter International Competition Performance Charts

Five steps to successful analysis of Baxter International Competition

Baxter International's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Baxter International in relation to its competition. Baxter International's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Baxter International in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Baxter International's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Baxter International, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Baxter International position

In addition to having Baxter International in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Pharmaceutical Products Thematic Idea Now

Pharmaceutical Products
Pharmaceutical Products Theme
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Pharmaceutical Products theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Pharmaceutical Products Theme or any other thematic opportunities.
View All  Next Launch

Additional Information and Resources on Investing in Baxter Stock

When determining whether Baxter International offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Baxter International's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Baxter International Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Baxter International Stock:
How To Invest In Baxter
Details
Is Baxter Stock a good investment?
Details
What is Baxter International's Net Worth?
Details
Largest Health Care Equipment & Supplies Companies
View
Largest Health Care Equipment & Services Companies
View
Check out Baxter International Correlation with its peers.
For information on how to trade Baxter Stock refer to our How to Trade Baxter Stock guide.
You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Altman
Z Score
Details
Intrinsic
Valuation
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Technical
Analysis
Details
Please note, there is a significant difference between Baxter International's value and its price as these two are different measures arrived at by different means. Investors typically determine if Baxter International is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Baxter International's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY